Investment Newsletter Subscription Price Temporarily Reduced

We are reducing the subscription price of Insider Monkey’s market beating newsletter for the next 12 days. Our strategy gained 81.1% since the end of August 2012, vs. 38.4% gain for the S&P 500 index ETF (SPY). Investors who followed our strategy since day 1 beat the market by 42.7 percentage points.

Warren Buffett
Insider Monkey’s research director has a Ph.D. in financial economics. He specializes in insider trading and has discovered novel ways of analyzing the insider transactions that beat the S&P 500 index by double digit rates. In 2012, he discovered an even better way of picking stocks: investing in the best stock picks of the best hedge fund managers. This strategy beat the S&P 500 index by 18 percentage points per year between 1999 and 2009. We launched our newsletter at the end of August 2012 and started sharing the stock picks of this strategy.

The annual subscription price of our quarterly newsletter is being reduced to $249 but it will go up to $299 on May 13th. This is a limited time opportunity to sign up now and lock in our current low price of $249 for as long as you remain a premium subscriber (download a free sample of the quarterly newsletter here).

We are also reducing the annual subscription price of our monthly newsletter to $250 for the next 12 days (download a free sample of the monthly newsletter here). In each issue of our monthly newsletter we try to share the best idea of our favorite hedge fund managers. For example, Michael Castor’s recommendations in the sample June newsletter returned an average of more than 100% since June. In the December issue of our monthly newsletter, we shared Michael’s new stock pick: Furiex Pharma (FURX). That stock returned more than 150% in less than 2 months. Find out Castor’s latest best ideas by signing up today.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!